Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Sclerosis
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 298 active Multiple Sclerosis trials
Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis
Study Type: Interventional
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
Study Type: Observational
A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
Study Type: Interventional Phase 4
Improving Learning in Hispanics With TBI or MS
Study Type: Interventional
Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis
Study Type: Interventional
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
Study Type: Observational
An Individualized-health eLibrary App for People With Multiple Sclerosis
Study Type: Interventional
A Health Action Process Approach Online Intervention for People With Multiple Sclerosis
Study Type: Interventional
There are 298 active Multiple Sclerosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now